IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,852,000 | +6.0% | 171,290 | +21.5% | 0.04% | +16.2% |
| Q4 2021 | $2,691,000 | -26.9% | 140,940 | -5.6% | 0.04% | -32.7% |
| Q3 2021 | $3,683,000 | -12.7% | 149,340 | -7.9% | 0.06% | -9.8% |
| Q2 2021 | $4,218,000 | +42.4% | 162,090 | +73.2% | 0.06% | +32.6% |
| Q1 2021 | $2,963,000 | -33.1% | 93,590 | -1.9% | 0.05% | -37.8% |
| Q4 2020 | $4,429,000 | +284.5% | 95,450 | +172.7% | 0.07% | +236.4% |
| Q3 2020 | $1,152,000 | +19.9% | 35,000 | 0.0% | 0.02% | +10.0% |
| Q2 2020 | $961,000 | -8.3% | 35,000 | 0.0% | 0.02% | -23.1% |
| Q1 2020 | $1,048,000 | -36.9% | 35,000 | -41.7% | 0.03% | +8.3% |
| Q4 2019 | $1,661,000 | -29.0% | 60,000 | -53.3% | 0.02% | -25.0% |
| Q3 2019 | $2,341,000 | -24.8% | 128,605 | +1.2% | 0.03% | -20.0% |
| Q2 2019 | $3,115,000 | +641.7% | 127,055 | +187.9% | 0.04% | +566.7% |
| Q1 2019 | $420,000 | +77.2% | 44,125 | +64.5% | 0.01% | +50.0% |
| Q4 2018 | $237,000 | -11.6% | 26,825 | +12.6% | 0.00% | +33.3% |
| Q3 2018 | $268,000 | -16.0% | 23,825 | -4.4% | 0.00% | -25.0% |
| Q2 2018 | $319,000 | +74.3% | 24,925 | +130.3% | 0.00% | +100.0% |
| Q1 2018 | $183,000 | – | 10,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |